Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)

PURPOSE: Docetaxel and cyclophosphamide (TC) was superior to doxorubicin and cyclophosphamide (AC) in a trial in early breast cancer. However, activity of TC relative to AC regimens with a taxane (TaxAC) is unknown. METHODS: In a series of three adjuvant trials, women were randomly assigned to TC fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Blum, Joanne L., Flynn, Patrick J., Yothers, Greg, Asmar, Lina, Geyer, Charles E., Jacobs, Samuel A., Robert, Nicholas J., Hopkins, Judith O., O'Shaughnessy, Joyce A., Dang, Chau T., Gómez, Henry Leonidas, Fehrenbacher, Louis, Vukelja, Svetislava J., Lyss, Alan P., Paul, Devchand, Brufsky, Adam M., Jeong, Jong-Hyeon, Colangelo, Linda H., Swain, Sandra M., Mamounas, Eleftherios P., Jones, Stephen E., Wolmark, Norman
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2017
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5549453/
https://ncbi.nlm.nih.gov/pubmed/28398846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.71.4147
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados